Home » Topics » Regulatory

Regulatory
RSS

Eisai launches new formulation of rufinamide in U.K.

April 16, 2012

European Commission approves Humira for new indication

April 12, 2012

Korlym now available in U.S.

April 11, 2012

FDA approves adjunct radioactive diagnostic for Alzheimer's disease

April 10, 2012

New product approved for T-cell leukemia-lymphoma

March 30, 2012

Kiklin capsules approved in Japan

March 30, 2012

FDA approves line extension for etravirine

March 29, 2012

Affymax and Takeda receive first approval for Omontys

March 28, 2012

Line extension for Taxol approved in Japan

March 22, 2012

Flagyl approved for additional indication in Japan

March 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 14, 2025.
FDA shift from animal testing fuels organoid, organ-on-chip demand
BioWorld Science
The U.S. FDA’s decision to phase out animal testing for INDs is driving a new market of alternative, nonanimal testing technologies like organoids and...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
Three med-tech IPOs on the horizon
BioWorld MedTech
April may not have brought rain to med-tech, but tariffs and financial uncertainty certainly dampened the enthusiasm for IPOs. With those clouds lifting, three...